Literature DB >> 1692034

Vitronectin binds to activated human platelets and plays a role in platelet aggregation.

E Asch1, E Podack.   

Abstract

Vitronectin (Vn) is a multifunctional 75-kD glycoprotein that is present in plasma and the extracellular matrix. Vn functions as a complement regulatory protein in plasma, and promotes the growth and attachment of cells in tissue culture. Recent cDNA cloning reveals that like other adhesive proteins, Vn contains the sequence Arg-Gly-Asp and binds to some members of the integrin class of adhesive membrane receptors. In liposomes, the platelet membrane glycoprotein complex IIb/IIIa binds Vn, as well as fibrinogen, von Willebrand factor, and fibronectin. We examined the binding of purified Vn to resting and stimulated human platelets. Vn bound to thrombin-stimulated platelets in a calcium-dependent, specific, and saturable manner with a Kd of 320 nM and 8,000 sites per platelet. Epinephrine or ADP stimulation led to specific binding with KdS of 93 and 116 nM, respectively. Binding was inhibited by the tetrapeptide Arg-Gly-Asp-Ser and by monoclonal and polyclonal antibodies to GPIIb/IIIa. Endogenous platelet Vn stores were identified in immunoblots of gel-filtered platelets and the surface expression of endogenous platelet Vn was thrombin inducible. Monoclonal as well as polyclonal antibodies to Vn inhibited platelet aggregation, suggesting that Vn plays a role in the formation of stable platelet aggregates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692034      PMCID: PMC296582          DOI: 10.1172/JCI114581

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Interaction of fibronectin with its receptor on platelets.

Authors:  J M Gardner; R O Hynes
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

2.  Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.

Authors:  D A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Exposure of binding sites for vitronectin on platelets following stimulation.

Authors:  P Thiagarajan; K L Kelly
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis.

Authors:  D Jenne; F Hugo; S Bhakdi
Journal:  Thromb Res       Date:  1985-05-15       Impact factor: 3.944

5.  Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin.

Authors:  V M Dixit; D M Haverstick; K O'Rourke; S W Hennessy; T J Broekelmann; J A McDonald; G A Grant; S A Santoro; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group.

Authors:  B Dahlbäck; E R Podack
Journal:  Biochemistry       Date:  1985-04-23       Impact factor: 3.162

7.  Association of thrombin-antithrombin III complex with vitronectin in serum.

Authors:  C R Ill; E Ruoslahti
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

8.  Localization of vitronectin (S-protein of complement) in normal human skin.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

9.  Vitronectin at sites of cell-substrate contact in cultures of rat myotubes.

Authors:  M Baetscher; D W Pumplin; R J Bloch
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

10.  Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin.

Authors:  S Suzuki; A Oldberg; E G Hayman; M D Pierschbacher; E Ruoslahti
Journal:  EMBO J       Date:  1985-10       Impact factor: 11.598

View more
  16 in total

1.  Activation of blood coagulation and fibrinolysis in vibration syndrome.

Authors:  R Shunto; A Shirakami; A Ohara; N Toibana; S Saito
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

2.  Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.

Authors:  B S Coller; J L Kutok; L E Scudder; D K Galanakis; S M West; G S Rudomen; K T Springer
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

3.  The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

Authors:  Y Ikeda; M Handa; K Kawano; T Kamata; M Murata; Y Araki; H Anbo; Y Kawai; K Watanabe; I Itagaki
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Proteins, platelets, and blood coagulation at biomaterial interfaces.

Authors:  Li-Chong Xu; James W Bauer; Christopher A Siedlecki
Journal:  Colloids Surf B Biointerfaces       Date:  2014-09-28       Impact factor: 5.268

5.  Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.

Authors:  B Titz; S Dietrich; T Sadowski; C Beck; A Petersen; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

6.  Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease.

Authors:  Hakan Ekmekci; Huseyin Sonmez; Ozlem B Ekmekci; Zeynep Ozturk; Nergiz Domanic; Emine Kokoglu
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

7.  Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

Authors:  H F Heynen; M Lozano Molero; P G de Groot; H K Nieuwenhuis; J J Sixma
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Prognostic utility of serum vitronectin levels in acute myocardial infarction.

Authors:  S Aslan; B Ikitimur; H A Cakmak; B Karadag; E Y Tufekcioglu; H Ekmekci; H Yuksel
Journal:  Herz       Date:  2014-05-15       Impact factor: 1.443

Review 9.  Platelet adhesion under flow.

Authors:  Zaverio M Ruggeri
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

Review 10.  Scarring vs. functional healing: Matrix-based strategies to regulate tissue repair.

Authors:  Timothy J Keane; Christine-Maria Horejs; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-02-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.